Studies have identified genomic aberrations that are responsible for constitutive activation of key transcription factors (such as TAL1/2, LMO1/2, and LYL1) involved in T cell differentiation as central drivers to T-ALL pathogenesis [16,17]. This evidence concerns the gene LMO1 and acute lymphoblastic leukemia.